These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 27146588

  • 1. Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation.
    Shindoh J, Akamatsu N, Tanaka T, Kaneko J, Tamura S, Sakamoto Y, Hasegawa K, Sugawara Y, Makuuchi M, Kokudo N.
    Clin Transplant; 2016 Aug; 30(8):880-5. PubMed ID: 27146588
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N.
    Clin Transpl; 2011 Aug; ():223-35. PubMed ID: 22755416
    [Abstract] [Full Text] [Related]

  • 4. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia.
    Sanada Y, Kawano Y, Miki A, Aida J, Nakamura K, Shimomura N, Ishikawa N, Arai T, Hirata Y, Yamada N, Okada N, Wakiya T, Ihara Y, Urahashi T, Yasuda Y, Takubo K, Mizuta K.
    Transpl Int; 2014 Apr; 27(4):383-90. PubMed ID: 24472036
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation].
    Fan S, Zhang Z.
    Zhonghua Yi Xue Za Zhi; 2001 Sep 25; 81(18):1092-4. PubMed ID: 11766604
    [Abstract] [Full Text] [Related]

  • 6. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.
    Ali MA, Elshobari MM, Salah T, Kandeel AR, Sultan AM, Elghawalby AN, Shehta A, Elsayed U, Fathy O, Yassen A, Wahab MA.
    Liver Transpl; 2017 Jan 25; 23(1):43-49. PubMed ID: 27516392
    [Abstract] [Full Text] [Related]

  • 7. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM, Verna EC, Lobritto SJ, Martinez M, Vittorio JM, Fox AN, Samstein B, Kato T, Griesemer AD, Emond JC.
    Transplantation; 2018 Jun 25; 102(6):953-960. PubMed ID: 29369249
    [Abstract] [Full Text] [Related]

  • 8. Human leukocyte antigen compatibility and lymphocyte cross-matching play no significant role in the current adult-to-adult living donor liver transplantation.
    Badawy A, Kaido T, Yoshizawa A, Yagi S, Fukumitsu K, Okajima H, Uemoto S.
    Clin Transplant; 2018 Apr 25; 32(4):e13234. PubMed ID: 29499077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-Term Outcomes of Living-Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study.
    Egawa H, Sakisaka S, Teramukai S, Sakabayashi S, Yamamoto M, Umeshita K, Uemoto S.
    Am J Transplant; 2016 Apr 25; 16(4):1248-57. PubMed ID: 26731039
    [Abstract] [Full Text] [Related]

  • 12. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid SV, Reed EF.
    Transplantation; 2015 Jul 25; 99(7):1416-22. PubMed ID: 26038872
    [Abstract] [Full Text] [Related]

  • 13. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 25; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 14. Living donor liver transplantation during the first 3 months of life.
    Kasahara M, Sakamoto S, Sasaki K, Uchida H, Kitajima T, Shigeta T, Narumoto S, Hirata Y, Fukuda A.
    Liver Transpl; 2017 Aug 25; 23(8):1051-1057. PubMed ID: 28220684
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunosuppression and Graft Rejection in Living-related HLA-identical Renal Transplantation: The RADOVFULL Study.
    Ossman R, Jamme M, Moulin B, Legendre C, Morelon E, Frimat L, Hourmant M, Durrbach A, Malvezzi P, Rostaing L, Luc Taupin J, Mesnard L, Rondeau E, RADOVFULL Study Group.
    Transplantation; 2020 Jun 25; 104(6):1256-1262. PubMed ID: 31465001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
    Kitajima K, Ogawa Y, Miki K, Kai K, Sannomiya A, Iwadoh K, Murakami T, Koyama I, Nakajima I, Fuchinoue S.
    Liver Transpl; 2017 Mar 25; 23(3):315-323. PubMed ID: 27862900
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for acute rejection in living donor liver transplantation.
    Sugawara Y, Makuuchi M, Kaneko J, Saiura A, Imamura H, Kokudo N.
    Clin Transplant; 2003 Aug 25; 17(4):347-52. PubMed ID: 12868991
    [Abstract] [Full Text] [Related]

  • 20. Prediction of acute cellular rejection by peripheral blood eosinophilia in pediatric living donor liver transplantation.
    Sanada Y, Ushijima K, Mizuta K, Urahashi T, Ihara Y, Wakiya T, Okada N, Yamada N, Egami S, Hishikawa S, Otomo S, Sakamoto K, Yasuda Y, Kawarasaki H.
    Transplant Proc; 2012 Jun 25; 44(5):1341-5. PubMed ID: 22664012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.